№ lp_1_2_53234
Public reimbursement assessment by the Pharmaceutical Benefits Advisory Committee examining the proposed PBS listing, pricing, and clinical equivalence of the Xorox brand of aciclovir eye ointment for treatment of herpes simplex keratitis in Australia.
Medicine: Aciclovir eye ointment 3% (3 mg/g), 4.5 g
Brand name: Xorox
Sponsor: Clinect Pty Ltd
ARTG listing date: 6 November 2020
Country: Australia
Indication: Herpes simplex keratitis
Regulatory authority: Therapeutic Goods Administration
Reimbursement scheme: Pharmaceutical Benefits Scheme
PBAC status: Not previously considered prior to this submission
Comparator products: AciVision, Zovirax
Submission type: Minor submission
Listing type requested: Restricted benefit, General Schedule
Prescriber types: Medical practitioners, nurse practitioners, optometrists
Legal framework: Therapeutic Goods Act 1989, Section 19A
Period discussed: 2014–2021
Source type: Public Summary Document
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.